Large multicenter clinical trials have led to two recently approved drugs for patients with
idiopathic pulmonary fibrosis (IPF); yet, both of these therapies only slow disease …

Interstitial lung fibrosis can develop as a consequence of occupational or medical exposure,
as a result of genetic defects, and after trauma or acute lung injury leading to …

The purpose of this manuscript is to revise and update the previous consensus statement on
inflammatory airway disease (IAD) in horses. Since 2007, a large number of scientific …

Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis
using animal models, yet few of these compounds have replicated these beneficial effects in …

Fibrogenesis is an often-deadly process with increasing world-wide incidence and limited
therapeutic options. Pulmonary fibrogenesis involves remodeling of the distal airspace and …

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown origin and progression that
primarily affects older adults. Accumulating clinical and experimental evidence suggests that …

The equine herpesviruses (EHVs) are highly successful pathogens of all members of the
Equidae family worldwide. 1-4 Of the nine EHVs characterized thus far, five types (EHV-1 to …

Equine Herpesvirus‐1 infection has been assessed according to the criteria of the Animal
Health Law (AHL), in particular criteria of: Article 7 on disease profile and impacts, Article 5 …

Respiratory disorders like asthma, emphysema, and pulmonary fibrosis affect millions of
Americans and many more worldwide. Despite advancements in medical research that have …

Equine gammaherpesviruses (γEHV) have been widely studied over the past 45years and
many isolates have been characterised. Despite this, the diagnosis of γEHV infection …